1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/35354
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTorres J.en
dc.contributor.authorFeagan B.G.en
dc.contributor.authorChande N.en
dc.contributor.authorMacDonald J.K.en
dc.contributor.authorParker C.E.en
dc.contributor.authorEast J.E.en
dc.contributor.authorBoyapati R.K.en
dc.date.accessioned2021-05-14T11:56:30Zen
dc.date.available2021-05-14T11:56:30Zen
dc.date.copyright2019en
dc.date.created20200506en
dc.date.issued2020-05-06en
dc.identifier.citationInflammatory Bowel Diseases. 25 (3) (pp 472-478), 2019. Date of Publication: 01 Mar 2019.en
dc.identifier.issn1078-0998en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/35354en
dc.description.abstractA symposium organized by the Cochrane IBD Group and presented at the 2017 Digestive Disease Week annual meeting reviewed the recent literature on several controversial topics in inflammatory bowel disease (IBD) management including the efficacy of oral aminosalicylates for induction and maintenance of Crohn's disease (CD), the feasibility of drug withdrawal in patients with quiescent CD, and strategies for detecting colon cancer in patients with IBD. This article summarizes the data presented at that session.Copyright © 2018 Crohn's & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.en
dc.languageenen
dc.languageEnglishen
dc.publisherOxford University Pressen
dc.relation.ispartofInflammatory Bowel Diseasesen
dc.subject.meshulcerative colitis-
dc.subject.meshaminosalicylic acid-
dc.subject.meshcorticosteroid-
dc.subject.meshmesalazine/ct-
dc.subject.meshmesalazine-
dc.subject.meshmethylprednisolone-
dc.subject.mesholsalazine-
dc.subject.mesholsalazine/ct-
dc.subject.meshprednisone-
dc.subject.meshsalazosulfapyridine-
dc.subject.meshremission-
dc.subject.meshCrohn Disease Activity Index-
dc.subject.meshdiarrhea-
dc.subject.meshcancer susceptibility-
dc.subject.meshcolon cancer-
dc.subject.meshCrohn disease-
dc.subject.meshdrug efficacy-
dc.subject.meshdrug safety-
dc.subject.meshinflammatory bowel disease-
dc.subject.meshinterstitial nephritis-
dc.subject.meshpancreatitis-
dc.subject.meshpericarditis-
dc.subject.meshpleurisy-
dc.subject.meshCrohn disease-
dc.titleControversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews.en
dc.typeReviewen
dc.identifier.affiliationGastroenterology and Hepatology-
dc.type.studyortrialReview article (e.g. literature review, narrative review)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/ibd/izy268-
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid30789982 [http://www.ncbi.nlm.nih.gov/pubmed/?term=30789982]en
dc.identifier.source631555564en
dc.identifier.institution(East) Translational Gastroenterology Unit and Oxford NIHR Biomedical Research Centre, Experimental Medicine Division, Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom (Boyapati) Department of Gastroenterology, Monash Health, Melbourne, VIC, Australia (Torres) Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States (Torres) Hospital Beatriz Angelo, Gastroenterology Division, Loures, Portugal (Parker, Feagan) Robarts Clinical Trials Inc., London, ON, Canada (MacDonald, Chande, Feagan) Cochrane IBD Group, University of Western Ontario, London, ON, Canada (Chande, Feagan) Division of Gastroenterology, Department of Medicine, University of Western Ontario, London, ON, Canada (Feagan) Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON N6A 5B6, Canadaen
dc.description.addressB.G. Feagan, Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON N6A 5B6, Canada. E-mail: brian.feagan@robartsinc.comen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.subect.keywordscancer detection colonoscopy Crohn's disease drug withdrawal ulcerative colitisen
dc.identifier.authoremailFeagan B.G.; brian.feagan@robartsinc.comen
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeReview-
Appears in Collections:Articles
Show simple item record

Page view(s)

10
checked on Sep 11, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.